Noxopharm Ltd (NOX) - Total Liabilities

Latest as of June 2025: AU$3.89 Million AUD ≈ $2.75 Million USD

Based on the latest financial reports, Noxopharm Ltd (NOX) has total liabilities worth AU$3.89 Million AUD (≈ $2.75 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Noxopharm Ltd operating cash flow efficiency to assess how effectively this company generates cash.

Noxopharm Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Noxopharm Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Noxopharm Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Noxopharm Ltd Competitors by Total Liabilities

The table below lists competitors of Noxopharm Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Icandy Interactive Ltd AU:ICI	Australia	AU$8.20 Million
Excel Realty N Infra Limited NSE:EXCEL	India	Rs28.93 Million
Careplus Group Bhd KLSE:0163	Malaysia	RM71.48 Million
MRO-TEK Realty Limited NSE:MRO-TEK	India	Rs1.66 Billion
NFL Biosciences SAS PA:ALNFL	France	€2.60 Million
Alligator Bioscience AB ST:ATORX	Sweden	Skr103.74 Million
Hanan Mor TA:HNMR	Israel	ILA2.84 Billion
Aerometrex Ltd AU:AMX	Australia	AU$24.84 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Noxopharm Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NOX company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.18	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.40	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	5.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.85	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Noxopharm Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Noxopharm Ltd (2016–2025)

The table below shows the annual total liabilities of Noxopharm Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$3.89 Million ≈ $2.75 Million	+201.99%
2024-06-30	AU$1.29 Million ≈ $911.78K	+22.12%
2023-06-30	AU$1.06 Million ≈ $746.61K	-57.38%
2022-06-30	AU$2.48 Million ≈ $1.75 Million	-65.02%
2021-06-30	AU$7.08 Million ≈ $5.01 Million	-1.63%
2020-06-30	AU$7.19 Million ≈ $5.09 Million	+25.10%
2019-06-30	AU$5.75 Million ≈ $4.07 Million	+30.66%
2018-06-30	AU$4.40 Million ≈ $3.11 Million	+1119.07%
2017-06-30	AU$361.04K ≈ $255.46K	+37.95%
2016-06-30	AU$261.72K ≈ $185.18K	--

About Noxopharm Ltd

AU:NOX Australia Biotechnology

Market Cap

$14.47 Million

AU$20.46 Million AUD

Market Cap Rank

#25923 Global

#1211 in Australia

Share Price

AU$0.07

Change (1 day)

-1.41%

52-Week Range

AU$0.04 - AU$0.13

All Time High

AU$1.58